Catyalyst Pharma (CPRX) Posts Q3 Loss of 5c/Share

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), which may not compare with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c